Problem statement: Answer the multiple-choice question.
Query: Which drug has a -21.413% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a COc1ccc(/C=N/NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)OCC(C)C)cc1[N+](=O)[O-]
b C/C(CC(=O)Nc1ccccn1)=N\NC(=O)c1ccccc1O
c CCO[C@@H]1OC(C(=O)N2CCCCCCC2)=C[C@H](c2ccc(C(F)(F)F)cc2)[C@H]1CCCO
Answer: c. CCO[C@@H]1OC(C(=O)N2CCCCCCC2)=C[C@H](c2ccc(C(F)(F)F)cc2)[C@H]1CCCO
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCO[C@@H]1OC(C(=O)N2CCCCCCC2)=C[C@H](c2ccc(C(F)(F)F)cc2)[C@H]1CCCO
CCO[C@@H]1OC(C(=O)N2CCCCCCC2)=C[C@H](c2ccc(C(F)(F)F)cc2)[C@H]1CCCO
azocan-1-yl-[(2R,3R,4S)-2-ethoxy-3-(3-hydroxypropyl)-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyran-6-yl]methanone